Effect of mannitol on brain metabolism and tissue oxygenation in severe haemorrhagic stroke

Raimund Helbok, Pedro Kurtz, J. Michael Schmidt, R. Morgan Stuart, Luis Fernandez, Rishi Malhotra, Mary Presciutti, Noeleen D. Ostapkovich, E. Sander Connolly, Kiwon Lee, Neeraj Badjatia, Stephan A. Mayer, Jan Claassen

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Background: The impact of osmotic therapies on brain metabolism has not been extensively studied in humans. The authors examined if mannitol treatment of raised intracranial pressure will result in an improvement in brain metabolism together with the expected drop in intracranial pressure (ICP). Methods: This is a retrospective review of prospectively collected data. Twenty episodes of raised ICP (>20 mm Hg) resistant to standard therapy that required infusions of mannitol were studied in 12 comatose patients with multimodality monitoring including ICP, PbtO2 and microdialysis. The authors compared mean arterial blood pressure, ICP, cerebral perfusion pressure, PbtO2, brain lactate, pyruvate and glucose using cerebral microdialysis, for 3 h preceding and 4 h after hyperosmolar therapy. Time-series data were analysed using a multivariable general linear model utilising generalised estimating equations for model estimation to account for within-subjects and between-subjects variations over time. Results: 20% mannitol solution (1 g/kg) was administered at the discretion of the attending neurointensivist. ICP decreased 30 min (from 27±13 to 19±16 mm Hg, p2 did not change significantly. The peak lactate-pyruvate ratio was recorded at the time of initiating osmotherapy (44±20) with an 18% decrease over 2 h following mannitol therapy (35±16; p=0.002). Brain glucose remained unaffected. Conclusions: Mannitol effectively reduces ICP and appeared to benefit brain metabolism as measured by the lactate-pyruvate ratio.

Original languageEnglish (US)
Pages (from-to)378-383
Number of pages6
JournalJournal of Neurology, Neurosurgery and Psychiatry
Volume82
Issue number4
DOIs
StatePublished - Apr 2011
Externally publishedYes

Fingerprint

Intracranial Pressure
Mannitol
Stroke
Brain
Pyruvic Acid
Lactic Acid
Microdialysis
Cerebrovascular Circulation
Arterial Pressure
Therapeutics
Glucose
Coma
Linear Models

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health
  • Surgery

Cite this

Effect of mannitol on brain metabolism and tissue oxygenation in severe haemorrhagic stroke. / Helbok, Raimund; Kurtz, Pedro; Schmidt, J. Michael; Stuart, R. Morgan; Fernandez, Luis; Malhotra, Rishi; Presciutti, Mary; Ostapkovich, Noeleen D.; Connolly, E. Sander; Lee, Kiwon; Badjatia, Neeraj; Mayer, Stephan A.; Claassen, Jan.

In: Journal of Neurology, Neurosurgery and Psychiatry, Vol. 82, No. 4, 04.2011, p. 378-383.

Research output: Contribution to journalArticle

Helbok, R, Kurtz, P, Schmidt, JM, Stuart, RM, Fernandez, L, Malhotra, R, Presciutti, M, Ostapkovich, ND, Connolly, ES, Lee, K, Badjatia, N, Mayer, SA & Claassen, J 2011, 'Effect of mannitol on brain metabolism and tissue oxygenation in severe haemorrhagic stroke', Journal of Neurology, Neurosurgery and Psychiatry, vol. 82, no. 4, pp. 378-383. https://doi.org/10.1136/jnnp.2009.198754
Helbok, Raimund ; Kurtz, Pedro ; Schmidt, J. Michael ; Stuart, R. Morgan ; Fernandez, Luis ; Malhotra, Rishi ; Presciutti, Mary ; Ostapkovich, Noeleen D. ; Connolly, E. Sander ; Lee, Kiwon ; Badjatia, Neeraj ; Mayer, Stephan A. ; Claassen, Jan. / Effect of mannitol on brain metabolism and tissue oxygenation in severe haemorrhagic stroke. In: Journal of Neurology, Neurosurgery and Psychiatry. 2011 ; Vol. 82, No. 4. pp. 378-383.
@article{651134bcb40046bcae4a0eef45c0d77a,
title = "Effect of mannitol on brain metabolism and tissue oxygenation in severe haemorrhagic stroke",
abstract = "Background: The impact of osmotic therapies on brain metabolism has not been extensively studied in humans. The authors examined if mannitol treatment of raised intracranial pressure will result in an improvement in brain metabolism together with the expected drop in intracranial pressure (ICP). Methods: This is a retrospective review of prospectively collected data. Twenty episodes of raised ICP (>20 mm Hg) resistant to standard therapy that required infusions of mannitol were studied in 12 comatose patients with multimodality monitoring including ICP, PbtO2 and microdialysis. The authors compared mean arterial blood pressure, ICP, cerebral perfusion pressure, PbtO2, brain lactate, pyruvate and glucose using cerebral microdialysis, for 3 h preceding and 4 h after hyperosmolar therapy. Time-series data were analysed using a multivariable general linear model utilising generalised estimating equations for model estimation to account for within-subjects and between-subjects variations over time. Results: 20{\%} mannitol solution (1 g/kg) was administered at the discretion of the attending neurointensivist. ICP decreased 30 min (from 27±13 to 19±16 mm Hg, p2 did not change significantly. The peak lactate-pyruvate ratio was recorded at the time of initiating osmotherapy (44±20) with an 18{\%} decrease over 2 h following mannitol therapy (35±16; p=0.002). Brain glucose remained unaffected. Conclusions: Mannitol effectively reduces ICP and appeared to benefit brain metabolism as measured by the lactate-pyruvate ratio.",
author = "Raimund Helbok and Pedro Kurtz and Schmidt, {J. Michael} and Stuart, {R. Morgan} and Luis Fernandez and Rishi Malhotra and Mary Presciutti and Ostapkovich, {Noeleen D.} and Connolly, {E. Sander} and Kiwon Lee and Neeraj Badjatia and Mayer, {Stephan A.} and Jan Claassen",
year = "2011",
month = "4",
doi = "10.1136/jnnp.2009.198754",
language = "English (US)",
volume = "82",
pages = "378--383",
journal = "Journal of Neurology, Neurosurgery and Psychiatry",
issn = "0022-3050",
publisher = "BMJ Publishing Group",
number = "4",

}

TY - JOUR

T1 - Effect of mannitol on brain metabolism and tissue oxygenation in severe haemorrhagic stroke

AU - Helbok, Raimund

AU - Kurtz, Pedro

AU - Schmidt, J. Michael

AU - Stuart, R. Morgan

AU - Fernandez, Luis

AU - Malhotra, Rishi

AU - Presciutti, Mary

AU - Ostapkovich, Noeleen D.

AU - Connolly, E. Sander

AU - Lee, Kiwon

AU - Badjatia, Neeraj

AU - Mayer, Stephan A.

AU - Claassen, Jan

PY - 2011/4

Y1 - 2011/4

N2 - Background: The impact of osmotic therapies on brain metabolism has not been extensively studied in humans. The authors examined if mannitol treatment of raised intracranial pressure will result in an improvement in brain metabolism together with the expected drop in intracranial pressure (ICP). Methods: This is a retrospective review of prospectively collected data. Twenty episodes of raised ICP (>20 mm Hg) resistant to standard therapy that required infusions of mannitol were studied in 12 comatose patients with multimodality monitoring including ICP, PbtO2 and microdialysis. The authors compared mean arterial blood pressure, ICP, cerebral perfusion pressure, PbtO2, brain lactate, pyruvate and glucose using cerebral microdialysis, for 3 h preceding and 4 h after hyperosmolar therapy. Time-series data were analysed using a multivariable general linear model utilising generalised estimating equations for model estimation to account for within-subjects and between-subjects variations over time. Results: 20% mannitol solution (1 g/kg) was administered at the discretion of the attending neurointensivist. ICP decreased 30 min (from 27±13 to 19±16 mm Hg, p2 did not change significantly. The peak lactate-pyruvate ratio was recorded at the time of initiating osmotherapy (44±20) with an 18% decrease over 2 h following mannitol therapy (35±16; p=0.002). Brain glucose remained unaffected. Conclusions: Mannitol effectively reduces ICP and appeared to benefit brain metabolism as measured by the lactate-pyruvate ratio.

AB - Background: The impact of osmotic therapies on brain metabolism has not been extensively studied in humans. The authors examined if mannitol treatment of raised intracranial pressure will result in an improvement in brain metabolism together with the expected drop in intracranial pressure (ICP). Methods: This is a retrospective review of prospectively collected data. Twenty episodes of raised ICP (>20 mm Hg) resistant to standard therapy that required infusions of mannitol were studied in 12 comatose patients with multimodality monitoring including ICP, PbtO2 and microdialysis. The authors compared mean arterial blood pressure, ICP, cerebral perfusion pressure, PbtO2, brain lactate, pyruvate and glucose using cerebral microdialysis, for 3 h preceding and 4 h after hyperosmolar therapy. Time-series data were analysed using a multivariable general linear model utilising generalised estimating equations for model estimation to account for within-subjects and between-subjects variations over time. Results: 20% mannitol solution (1 g/kg) was administered at the discretion of the attending neurointensivist. ICP decreased 30 min (from 27±13 to 19±16 mm Hg, p2 did not change significantly. The peak lactate-pyruvate ratio was recorded at the time of initiating osmotherapy (44±20) with an 18% decrease over 2 h following mannitol therapy (35±16; p=0.002). Brain glucose remained unaffected. Conclusions: Mannitol effectively reduces ICP and appeared to benefit brain metabolism as measured by the lactate-pyruvate ratio.

UR - http://www.scopus.com/inward/record.url?scp=79952738418&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952738418&partnerID=8YFLogxK

U2 - 10.1136/jnnp.2009.198754

DO - 10.1136/jnnp.2009.198754

M3 - Article

VL - 82

SP - 378

EP - 383

JO - Journal of Neurology, Neurosurgery and Psychiatry

JF - Journal of Neurology, Neurosurgery and Psychiatry

SN - 0022-3050

IS - 4

ER -